130. Management of Complex, Multidrug-Resistant Tuberculosis
Session: Symposium: Update on TB Diagnostics and Treatment of Complex, Multidrug-Resistant TB
Friday, October 21, 2011: 9:29 AM
Room: 253ABC

Barbara Seaworth, MD, FIDSA, University of Texas Health Center, San Antonio, TX; Texas Center for Infectious Diseases, San Antonio, TX

Dr. Seaworth received her MD from Washington University School of Medicine in St Louis, Missouri, completed an internal medicine residency at Wilford Hall USAF Medical Center, and a fellowship in infectious disease at Duke University Medical Center. She is a fellow of IDSA and the American College of Physicians. Dr. Seaworth joined the staff at the Texas Center for Infectious Diseases (TCID) in 1987 and began her career in the care of tuberculosis patients. At that time, she was one of a handful of physicians involved in caring for HIV/AIDS patients including those that had HIV –TB co-infection. She was responsible for the care of all patients with MDR TB referred to the hospital and its outpatient clinic until 1993. Following 1993 she has continued to assist in the care of MDR and XDR TB patients as a consultant. She was named a TB Consultant for the Texas Department of State Health Services and appointed Director of the (then) Texas TB Resource and Education Center in 1993. In 2005 she became the Medical Director and Principal Investigator of the Heartland National TB Center (HNTC) which provides medical education and consultation to a 13 state region. She is nationally recognized as an expert in the care of MDR-and XDR-TB patients. For the past 15 years, Dr. Seaworth has served as a medical consultant to the US-Mexico Binational program providing education and medical recommendations for MDR and complicated drug resistant cases. This program was selected as a 2010 Border Model of Excellence in Tuberculosis Surveillance and Control by the U.S.-Mexico Border Health Commission. She provides medical consultation on MDR and XDR-TB patients throughout the Heartland Region, and more recently internationally through a CDC-sponsored program to panel physicians caring for potential U.S. immigrants and refugees with MDR TB. She participated in a pilot grant from USAID from 2009-2010 to provide ongoing consultation to Mexican physicians. Throughout the course of her career, she has served on numerous committees and workgroups that impact the care of TB patients nationally and internationally. She has served on the Health and Human Services Advisory Committee for the Elimination of Tuberculosis since 2005. In June 2010, she was recognized by the National TB Controller’s Association with its inaugural William Stead Physician of the Year Award.

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.